James A. Posey
Department of Medicine
The University of Alabama at Birmingham
263 Wallace Tumor Institute
1530 3rd Avenue South
USA
Name/email consistency: high
- Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies. Posey, J.A., Wang, H., Hamilton, J., Delgrosso, A., Zhang, R., Freda, T., Zamboni, W.C. Cancer Chemother. Pharmacol. (2005)
- Phase 1 study of weekly polyethylene glycol-camptothecin in patients with advanced solid tumors and lymphomas. Posey, J.A., Saif, M.W., Carlisle, R., Goetz, A., Rizzo, J., Stevenson, S., Rudoltz, M.S., Kwiatek, J., Simmons, P., Rowinsky, E.K., Takimoto, C.H., Tolcher, A.W. Clin. Cancer Res. (2005)
- A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma. Posey, J.A., Ng, T.C., Yang, B., Khazaeli, M.B., Carpenter, M.D., Fox, F., Needle, M., Waksal, H., LoBuglio, A.F. Clin. Cancer Res. (2003)